SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Möttönen TT, Hannonen P, Toivanen J, Rekonen A, Oka M. Value of joint scintigraphy in the prediction of erosiveness in early rheumatoid arthritis. Ann Rheum Dis 1988; 47: 1839.
  • 2
    McQueen FM. Magnetic resonance imaging in early inflammatory arthritis: what is its role? Rheumatology 2000; 39: 7006.
  • 3
    Reiser MF, Naegele M. Inflammatory joint disease: static and dynamic gadolinium-enhanced MR imaging. J Magn Reson Imaging 1993; 3: 30710.
  • 4
    Ostergaard M, Stoltenberg M, Lovgreen-Nielsen P, Volck B, Sonne-Holm S, Lorenzen I. Quantification of synovitis by MRI: correlation between dynamic and static gadolinium-enhanced magnetic resonance imaging and microscopic and macroscopic signs of synovial inflammation. Magn Reson Imaging 1998; 16: 74354.
  • 5
    Krohn KA. Evaluation of alternative approaches for imaging cellular growth. Q J Nucl Med 2001; 45: 1748.
  • 6
    Rennen HJ, Boerman OC, Oyen WJ, Corstens FH. Imaging infection/inflammation in the new millennium. Eur J Nucl Med Mol Imaging 2001; 28: 24152.
  • 7
    Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002; 32: 293321.
  • 8
    Zeisel SH. Dietary choline: biochemistry, physiology, and pharmacology. Annu Rev Nutr 1981; 1: 95121.
  • 9
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 10
    Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991; 34: 121827.
  • 11
    Hamacher K, Coenen HH, Stocklin G. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 1986; 27: 2358.
  • 12
    Lehikoinen PK, Bergman JR, Hällsten UM, Kokkomäki EPJ, Eskola OI, Solin OH, et al. A simple synthesis of [methyl-11C]choline. J Labelled Cpd Radiopharm 1999; 42: S4802.
  • 13
    DeGrado TR, Turkington TG, Williams JJ, Stearns CW, Hoffman JM, Coleman RE. Performance characteristics of a whole-body PET scanner. J Nucl Med 1994; 35: 1398406.
  • 14
    Roivainen A, Forsback S, Grönroos T, Lehikoinen P, Kähkönen M, Sutinen E, et al. Blood metabolism of [methyl-11C]choline: implications for in vivo imaging with positron emission tomography. Eur J Nucl Med Mol Imaging 2000; 27: 2532.
  • 15
    Eckelman WC, Tatum JL, Kurdziel KA, Croft BY. Quantitative analysis of tumor biochemistry using PET and SPECT. Nucl Med Biol 2000; 27: 6335.
  • 16
    Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 17.
  • 17
    Manthey N, Reinhard P, Moog F, Knesewitsch P, Hahn K, Tatsch K. The use of [18 F]fluorodeoxyglucose positron emission tomography to differentiate between synovitis, loosening and infection of hip and knee prostheses. Nucl Med Commun 2002; 23: 64553.
  • 18
    Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 1995; 36: 13016.
  • 19
    Polisson RP, Schoenberg OI, Fischman A, Rubin R, Simon LS, Rosenthal D, et al. Use of magnetic resonance imaging and positron emission tomography in the assessment of synovial volume and glucose metabolism in patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 81925.
  • 20
    Palmer WE, Rosenthal DI, Schoenberg OI, Fischman AJ, Simon LS, Rubin RH, et al. Quantification of inflammation in the wrist with gadolinium-enhanced MR imaging and PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1995; 196: 64755.
  • 21
    Danfors T, Bergström M, Feltelius N, Ahlström H, Westerberg G, Långström B. Positron emission tomography with 11C-D-deprenyl in patients with rheumatoid arthritis: evaluation of knee joint inflammation before and after intra-articular glucocorticoid treatment. Scand J Rheumatol 1997; 26: 438.
  • 22
    Negendank W. Studies of human tumors by MRS: a review. NMR Biomed 1992; 5: 30324.
  • 23
    Usenius JP, Vainio P, Hernesniemi J, Kauppinen RA. Choline-containing compounds in human astrocytomas studied by 1H NMR spectroscopy in vivo and in vitro. J Neurochem 1994; 63: 153843.
  • 24
    Sabatier J, Gilard V, Malet-Martino M, Ranjeva JP, Terral C, Breil S, et al. Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. Invest Radiol 1999; 34: 2305.
  • 25
    Shinoura N, Nishijima M, Hara T, Haisa T, Yamamoto H, Fujii K, et al. Brain tumors: detection with C-11 choline PET. Radiology 1997; 202: 497503.
  • 26
    Ohtani T, Kurihara H, Ishiuchi S, Saito N, Oriuchi N, Inoue T, et al. Brain tumour imaging with carbon-11 choline: comparison with FDG PET and gadolinium-enhanced MR imaging. Eur J Nucl Med Mol Imaging 2001; 28: 166470.
  • 27
    Jager PL, Que TH, Vaalburg W, Pruim J, Elsinga P, Plukker JT. Carbon-11 choline or FDG-PET for staging of oesophageal cancer? Eur J Nucl Med Mol Imaging 2001; 28: 18459.
  • 28
    Kobori O, Kirihara Y, Kosaka N, Hara T. Positron emission tomography of esophageal carcinoma using (11)C-choline and (18)F-fluorodeoxyglucose: a novel method of preoperative lymph node staging. Cancer 1999; 86: 163848.
  • 29
    Kotzerke J, Prang J, Neumaier B, Volkmer B, Guhlmann A, Kleinschmidt K, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med Mol Imaging 2000; 27: 14159.
  • 30
    De Jong IJ, Pruim J, Elsinga PH, Jongen MM, Mensink HJ, Vaalburg W. Visualisation of bladder cancer using (11)C-choline PET: first clinical experience. Eur J Nucl Med Mol Imaging 2002; 29: 12838.
  • 31
    Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, et al. Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 2003; 62: 32938.
  • 32
    Radiation dose of patients from radiopharmaceuticals: recalculated data for frequently used radiopharmaceuticals [addendum 2 to ICRP publication 53]. Ann ICRP 1998; 28: 1126.